We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
+11.54%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$5.91B
AUM Growth
+$723M
Cap. Flow
+$207M
Cap. Flow %
3.5%
Top 10 Hldgs %
67.97%
Holding
140
New
16
Increased
56
Reduced
33
Closed
12

Top Sells

Rank Stock Value
1
RAI
Reynolds American Inc
RAI
+$279M
2
BBWI icon
Bath & Body Works
BBWI
+$245M
3
CVS icon
CVS Health
CVS
+$244M
4
TSM icon
TSMC
TSM
+$6.36M
5
DVA icon
DaVita
DVA
+$6.35M

Sector Composition

Rank Sector Weight
1 Financials 27.75%
2 Healthcare 19.16%
3 Consumer Discretionary 17.5%
4 Communication Services 14.74%
5 Materials 7.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PBYI icon
101
Puma Biotechnology
PBYI
$398M
$1.24M 0.02%
33,369
+3,369
+11% +$123K
DCOY
102
Decoy Therapeutics
DCOY
$2.14M
0
JPM icon
103
JPMorgan Chase
JPM
$916B
$905K 0.02%
10,300
NEE icon
104
NextEra Energy
NEE
$184B
$890K 0.02%
27,716
-34,684
-56% -$1.09M
ZVRA icon
105
Zevra Therapeutics
ZVRA
$578M
$890K 0.02%
11,356
+1,043
+10% +$63.4K
CVX icon
106
Chevron
CVX
$382B
$827K 0.01%
+7,700
New +$864K
VRTX icon
107
Vertex Pharmaceuticals
VRTX
$123B
$746K 0.01%
6,818
+812
+14% +$71.5K
HRL icon
108
Hormel Foods
HRL
$14.2B
$667K 0.01%
+19,250
New +$687K
FIS icon
109
Fidelity National Information Services
FIS
$24.2B
$639K 0.01%
8,030
-11,270
-58% -$906K
MDT icon
110
Medtronic
MDT
$112B
$628K 0.01%
7,800
AZO icon
111
AutoZone
AZO
$51.3B
$606K 0.01%
837
-690
-45% -$511K
ADP icon
112
Automatic Data Processing
ADP
$109B
$595K 0.01%
5,815
-6,185
-52% -$631K
INNL
113
DELISTED
Innocoll Holdings plc Ordinary Shares
INNL
$331K 0.01%
295,184
RDUS
114
DELISTED
Radius Health, Inc.
RDUS
$286K ﹤0.01%
7,397
+43
+0.6% +$1.8K
LUMO
115
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$261K ﹤0.01%
+1,204
New +$172K
ACAD icon
116
Acadia Pharmaceuticals
ACAD
$4.51B
$258K ﹤0.01%
7,505
-679
-8% -$24K
IONS icon
117
Ionis Pharmaceuticals
IONS
$8.93B
$241K ﹤0.01%
6,002
+2
+0% +$90
BLUE
118
DELISTED
bluebird bio
BLUE
$223K ﹤0.01%
190
-59
-24% -$60.2K
KPTI icon
119
Karyopharm Therapeutics
KPTI
$155M
$217K ﹤0.01%
1,129
+262
+30% +$42.1K
BAP icon
120
Credicorp
BAP
$30.5B
$189K ﹤0.01%
1,161
-530
-31% -$87.1K
ASXC
121
DELISTED
Asensus Surgical, Inc.
ASXC
$182K ﹤0.01%
11,538
LXRX icon
122
Lexicon Pharmaceuticals
LXRX
$1.03B
$167K ﹤0.01%
11,677
+280
+2% +$4.15K
SNDX icon
123
Syndax Pharmaceuticals
SNDX
$1.7B
$163K ﹤0.01%
+11,900
New +$124K
ESPR
124
DELISTED
Esperion Therapeutics
ESPR
$162K ﹤0.01%
+4,600
New +$105K
ICPT
125
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$150K ﹤0.01%
1,323
-116
-8% -$13.5K

Similar funds

C WorldWide Group's Q1 2017 Portfolio in Review

As of Q1 2017, C WorldWide Group held 140 positions worth $5.91B, up 14% from $5.18B the previous quarter. Its ten largest holdings account for 68% of the portfolio.

C WorldWide Group deployed $207M of net new capital in Q1 2017, opening 16 new positions and adding to 56 existing holdings. Its largest new stake was Booking.com: 2,659,100 shares worth $189M.

By sector, the portfolio is most concentrated in Financials at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Reynolds American Inc, an estimated $279M trimmed.

  • C WorldWide Group's largest Q1 2017 buy was Booking.com: 2,659,100 shares worth $189M.
  • C WorldWide Group added most to Thermo Fisher Scientific in Q1 2017, an estimated $271M increase.
  • C WorldWide Group's biggest Q1 2017 reduction was Reynolds American Inc, cutting an estimated $279M.
  • C WorldWide Group fully exited Bath & Body Works in Q1 2017, selling an estimated $245M.
  • C WorldWide Group's ten largest holdings make up 68% of its $5.91B portfolio in Q1 2017.
  • C WorldWide Group opened 16 new positions and closed 12 in Q1 2017.
  • C WorldWide Group's portfolio value rose 14% quarter-over-quarter to $5.91B.

Based on C WorldWide Group's 13F filing for Q1 2017, filed 1 May 2017.